Moderate to Severe Eczema

Am I eligible for this study?

To find out, please answer yes or no to the following questions.


Are you 18 years of age or older?


Do you have moderate to sever atopic dermatitis?



The purpose of the study is to determine the safety and effectiveness of an investigational dual treatment of two investigational drugs (one oral and one via subcutaneous injection),versus placebo for adults with moderate to severe atopic dermatitis (aka eczema) who are currently being treated with topical medication(s) only. The study will last up to 28 weeks with up to 10 clinic visits and 1 telephone contact. Qualified participants will receive study-related care and medication at no cost, and may be compensated for study-related time and travel.

18 years of age or older
Male and Female
Atopic Dermatitis (Eczema)

Why take part?

Participants will receive study-related doctor’s care, study medication at no cost. Compensation for study-related time and travel may be available.Millions of people lack the treatment they need to manage their conditions. As one of the largest and most recognized clinical study organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself.

Who is Synexus?

Synexus is a company dedicated to conducting clinical studies, and has been investigating the effectiveness of new study drugs and treatments for more than 20 years. We provide a friendly, relaxed environment in our own clinics where you have the chance to help shape the future of health for yourself and for others.We are sure you probably have more questions about the study, and we would be happy to take the time to give you more details.

All Synexus studies are approved by an independent ethics committee.

Recruiting at the following locations

Synexus - Santa Rosa Quick view
Synexus - Greer Quick view
Synexus - Anderson Quick view

Still unsure?

Feel free to call us on to find out more about this study.


Your feedback is vital to the success of our research. Please fill in the form fields below.